Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant. Issue 4 (7th May 2021)

• Record Type: Journal Article
• Authors: Papayannidis, Cristina; Sartor, Chiara; Dominietto, Alida; Zappone, Elisabetta; Arpinati, Mario; Marconi, Giovanni; Cristiano, Gianluca; Nanni, Jacopo; Parisi, Sarah; Barbato, Francesco; Paolini, Stefania; Soverini, Simona; Terragna, Carolina; Robustelli, Valentina; Testoni, Nicoletta; Chirumbolo, Gabriella; Curti, Antonio; Cavo, Michele; Bonifazi, Francesca
• Is Part Of: Hematological oncology. Volume 39:Issue 4(2021)
• Page Start: 580
• Page End: 583
• Publication Date: 2021-05-07
• Subjects: acute lymphoblastic leukemia -- donor lymphocyte infusion -- inotuzumab Ozogamicin -- stem cell transplant; Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2886
• Languages: English
• ISSNs: 0278-0232